50 related articles for article (PubMed ID: 4355029)
1. Genetic factors in chronic remittent Friend disease.
Dawson PJ; Fieldsteel AH
Cancer Res; 1973 Oct; 33(10):2456-8. PubMed ID: 4355029
[No Abstract] [Full Text] [Related]
2. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
3. Resistance of G mice to murine leukemia virus infection: apparent disparity in in vivo and in vitro resistances.
Yoshikura H; Odaka T
J Natl Cancer Inst; 1978 Aug; 61(2):461-3. PubMed ID: 277731
[TBL] [Abstract][Full Text] [Related]
4. Inheritance of susceptibility and resistance to Rauscher leukaemia virus.
Tóth FD; Váczi L; Balogh M
Acta Microbiol Acad Sci Hung; 1973; 20(3):183-9. PubMed ID: 4798829
[No Abstract] [Full Text] [Related]
5. Genetic factors in the natural history of murine leukemia virus infection: G. H. A. Clowes Memorial Lecture.
Rowe WP
Cancer Res; 1973 Dec; 33(12):3061-8. PubMed ID: 4357347
[No Abstract] [Full Text] [Related]
6. Effects of tacrolimus on infection of Friend murine leukemia virus to Fv-4 gene heterozygous mice.
Zhang FM; Yang BF; Gu HX; Chen XB; Zhong ZH; Cheng Z
Acta Pharmacol Sin; 2004 Feb; 25(2):208-12. PubMed ID: 14769211
[TBL] [Abstract][Full Text] [Related]
7. In vivo studies of increased incidence of sister chromatid exchanges in target cells of replication-component Friend murine leukemia virus.
Palitti F; Matarese GP; Diana G; Sorrentino V; Rossi GB
Cancer Res; 1982 Nov; 42(11):4753-7. PubMed ID: 7127311
[No Abstract] [Full Text] [Related]
8. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
9. Friend viral pathogenesis in C57BL/6 reversible DBA/2 allophenic mice.
Dewey MJ; Eldridge PW
Exp Hematol; 1982 Oct; 10(9):723-31. PubMed ID: 7173342
[TBL] [Abstract][Full Text] [Related]
10. Construction of a D2.B6-Fv-2r congenic mouse strain: nonlethality of the homozygous Fv-2' genotype.
Dizik M; Elliott RW; Lilly F
J Natl Cancer Inst; 1981 Apr; 66(4):755-60. PubMed ID: 6939921
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
Sanfilippo F; Kao KJ; Pizzo SV; Collins JJ
J Natl Cancer Inst; 1980 Mar; 64(3):547-53. PubMed ID: 6928240
[No Abstract] [Full Text] [Related]
12. The influence of age on chronic remittent Friend disease.
Dawson PJ; Fieldsteel AH
Cancer Res; 1971 Jul; 31(7):974-80. PubMed ID: 4934678
[No Abstract] [Full Text] [Related]
13. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V; Hilbert D; Wolff L
Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
[TBL] [Abstract][Full Text] [Related]
14. Expression of Friend leukemia virus and spleen focus-forming virus-specific sequences in erythroid bursts and granulocyte-macrophage colonies from spleen and marrow of mice infected with Friend leukemia virus.
Colletta G; Di Fiore PP; Fusco A; Lettieri F; Covelli A; Peschle C
Cancer Res; 1983 Feb; 43(2):598-603. PubMed ID: 6293700
[TBL] [Abstract][Full Text] [Related]
15. Analysis of globin genes from murine erythroleukemia cells.
Reuben RC; Lenny AB; Stotish RL
J Mol Appl Genet; 1983; 2(2):181-9. PubMed ID: 6308119
[TBL] [Abstract][Full Text] [Related]
16. Construction of a DBA/2.Fv-2r congenic strain. Apparent lethality of the homozygous Fv-2r genotype: brief communication.
Blank KJ; Lilly F
J Natl Cancer Inst; 1977 Oct; 59(4):1335-6. PubMed ID: 904004
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cells in Friend murine leukemia virus-infected mice undergoing chemotherapy: effects of 5-FU.
Seidel HJ; Kreja L
Cancer Treat Rep; 1982 Nov; 66(11):1949-56. PubMed ID: 7139639
[TBL] [Abstract][Full Text] [Related]
18. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
[TBL] [Abstract][Full Text] [Related]
19. Interferon and friend virus-induced leukemic cells: in vivo and in vitro interactions.
Rossi GB; Matarese GP; Marchegiani M; Grappelli C
Boll Ist Sieroter Milan; 1974; 53(4):538-42. PubMed ID: 4451582
[No Abstract] [Full Text] [Related]
20. Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice.
Genovesi EV; Livnat D; Collins JJ
J Natl Cancer Inst; 1983 Feb; 70(2):311-22. PubMed ID: 6337292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
